Clenbuterol 40 mcg Magnus Pharmaceuticals

Clenbuterol 40 mcg Magnus Pharmaceuticals is an anti-asthma drug whose properties make it one of the most indispensable drugs in bodybuilding and fitness. It is a powerful fat burner that works well in cutting classes. It is not a steroid, it is not associated with sex hormones, but only activates special receptors, which causes lipolysis. Clenbuterol 40 mcg Magnus Pharmaceuticals is suitable for both men and women. It has no androgenic or oestrogenic effects.

Key benefits of Clenbuterol 40 mcg Magnus Pharmaceuticals

Clenbuterol acts on beta-2-adrenergic receptors. This stimulates the production of two neurotransmitters: epinephrine and norepinephrine. As you know, these are natural fat burners.

In addition, the drug has an anti-catabolic effect. It does not allow muscle cells to collapse, thus preserving muscle mass. This is important in cutting bodybuilding classes.

In addition, the tool blocks the process of fat deposition and stimulates the production of thyroid hormones. They are also powerful fat burners. Thus, fat burning is an indirect effect of Clenbuterol.

So, the main results of taking the drug:

• fat burning;
• muscle dryness;
• strength growth;
• increased endurance;
• slight anabolic and anti-catabolic effect.

The tool also reduces appetite, therefore, by using it, it will be easier to follow a diet to lose weight.

Possible side effects

Clenbuterol 40 mcg is considered safe. It rarely causes serious side effects. There are no irreversible consequences of taking it, but there are such symptoms:

• heart palpitations;
• trembling of the body;
• increased sweating;
• sleeping problems;
• increased blood pressure.

In some cases, seizures occur, which may indicate an overdose. The drug may cause headaches, which are associated with increased blood pressure.

Due to some of the properties of the drug, people with sensitive intestines develop diarrhoea and bloating.

All negative symptoms are resolved by taking concomitant medications. Treatment is symptomatic. Most of these phenomena disappear on their own a few days after the start of treatment.

Dosage and intake rules

The drug has a short half-life, so you should take it every day. To achieve a pronounced effect of weight loss and fat removal from problem areas, it is recommended:

• men: 120-140 mcg per day;
• women: 80-100 mcg.

The duration of the course is 2 weeks. After that, you should take a break, because the receptors affected by clenbuterol get used to it and the effectiveness decreases. During the break, it is recommended to take Ketotifen. It is a substance that increases the sensitivity of the receptors, i.e. it makes addiction impossible. If you do not use this drug, you take a break for a longer period of time.

This will help to improve the results of the course:

• take protein supplements
• use cortisol blockers (so that there is no swelling);
• weight loss diet or nutrition for a cutting cycle.

Please consult your doctor before use. Clenbuterol 40 mcg Magnus Pharmaceuticals is incompatible with certain drugs. In case of their combination, serious side effects may occur. Also avoid overdosing. It is best to start with the lowest dose to test your tolerance.

List of references

1. McKeever TM, Evans D, Thompson N, Britton J. “Clenbuterol, a beta(2)-agonist, predisposes to skeletal muscle weakness in patients with chronic heart failure.” Thorax. 2004;59(8):735-737.
2. Spiller HA, James KJ, Scholzen S, et al. “A descriptive study of adverse events from clenbuterol misuse and abuse for weight loss and bodybuilding.” Subst Abus. 2013;34(3):306-312.
3. Prather ID, Brown DE, North P, Wilson JR. “Reversible myocardial dysfunction associated with tachycardia and amine therapy.” Ann Intern Med. 1994;121(10):763-769.
4. Angell PJ, Chester N, Sculthorpe N, Whyte G, George K, Somauroo J. “Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician.” Br J Sports Med. 2012;46 Suppl 1:i78-i84.
5. Haller CA, Benowitz NL. “Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.” N Engl J Med. 2000;343(25):1833-1838.